Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis: Report of 3 Cases
Open Access
- 28 February 2011
- journal article
- case report
- Published by Elsevier BV in Ophthalmology
- Vol. 118 (2), 324-331
- https://doi.org/10.1016/j.ophtha.2010.06.041
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Safety of Corneal Collagen Cross-linking With UV-A and Riboflavin in Progressive KeratoconusCornea, 2010
- Antimicrobial Efficacy of Riboflavin/UVA Combination (365 nm) In Vitro for Bacterial and Fungal Isolates: A Potential New Treatment for Infectious KeratitisInvestigative Ophthalmology & Visual Science, 2008
- Acanthamoeba Keratitis: 2007: A Train Wreck in Slow MotionEye & Contact Lens: Science & Clinical Practice, 2007
- Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wearThe Korean Journal of Parasitology, 2006
- Trends in Contact Lens???Related Corneal UlcersCornea, 2005
- Results of a trial of combined propamidine isethionate and neomycin therapy for acanthamoeba keratitisOphthalmology, 1999
- A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992Eye, 1993
- Acanthamoeba keratitis successfully treated medically.British Journal of Ophthalmology, 1985
- Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical (O2−) mechanismsToxicology Letters, 1985
- Virulence and Resistance to Superoxide, Low pH and Hydrogen Peroxide among Strains of Mycobacterium tuberculosisJournal of General Microbiology, 1978